Do either of the following sound familiar – “Appears completely excised” OR “Tumor is completely excised with narrow margins”. This installment of The Hope Line Spring 2019 edition highlights Dr. LaDue’s article ‘Narrow’s Not Enough!’. We also share a story about one of our radiation champions, Brandy and touch a bit on what PetXMark liquid…
This installment of The Hope Line Newsletter Winter 2018 edition, covers common questions on lymphoma and Dr. Miller shares a story about one of our amazing patients, Sport. Click the following link to read the latest newsletter, highlighting Dr. Miller’s article ‘The Lymphoma Low-down’. Read The Hope Line Newsletter – Winter 2018
This installment of The Hope Line Newsletter Fall 2018 edition, helps shed some light on the transfusion process. Click the following link to read the latest newsletter, highlighting Dr. Deitz’ article ‘Transfusion Confusion’. Read The Hope Line Newsletter – Fall 2018
Sugars? Spice? Is anything nice? Diet changes in cancer patients can be a tricky subject. Click the following link to read our summer newsletter addressing just this! Also, check out the criteria for the Osteosarcoma Study for dogs that have undergone amputation and chemotherapy. Read The Hope Line Newsletter – Summer 2018
Here at SEVO-Med we are starting off 2018 with “What’s SNOT to know about nasal discharge in dogs”. Also take a look at the clinical trial opportunities that are available through PetCure Oncology at SEVO-Med. Don’t forget to sign up for our CPR training course that is available for local clinics.ions. Read The Hope Line…
In this fall edition of The Hope Line, Dr. Neumann discusses how Metronomic Chemotherapy can be utilized in a number of situations. Read The Hope Line Newsletter – Fall 2017
Joan of Arc, clinical trials and welcoming Dr. Kristina Miller to SEVO-Med are highlighted in the The Hope Line Newsletter – Winter 2017.
SEVO-Med introduces new, less invasive PetCure cancer therapy at Orange Park clinic.
Interview with owners of Spartacus, being treated for cancer with the new SRS treatment technology from PetCure, and Dr. Tracy LaDue. Check out the story here.
Dr. Tracy LaDue, founder of SEVO-Med, talks with hosts about the partnership with PetCure Oncology and the introduction of game-changing stereotactic radiosurgery (SRS) — which dramatically reduces cancer treatments necessary for pets and allows the safe, effective treatment of cancers that previously couldn’t be treated in pets. Full interview here.